Ketryx Revenue and Competitors

Boston, MA USA

Location

$18M

Total Funding

SaaS

Industry

Estimated Revenue & Valuation

  • Ketryx's estimated annual revenue is currently $10.2M per year.(i)
  • Ketryx's estimated revenue per employee is $144,000
  • Ketryx's total funding is $18M.

Employee Data

  • Ketryx has 71 Employees.(i)
  • Ketryx grew their employee count by 109% last year.

Ketryx's People

NameTitleEmail/Phone
1
CEO & FounderReveal Email/Phone
2
CTO & FounderReveal Email/Phone
3
Chief Operating OfficerReveal Email/Phone
4
Chief StaffReveal Email/Phone
5
VP RA/QAReveal Email/Phone
6
VP MarketingReveal Email/Phone
7
Director Client OperationsReveal Email/Phone
8
Director SolutionsReveal Email/Phone
9
Director Client OperationsReveal Email/Phone
10
Senior People Operations ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.7M3728%$9.8MN/A
#2
$0.1M6-65%N/AN/A
#3
$6.4M50N/AN/AN/A
#4
$16M1006%N/AN/A
#5
$10.5M7330%N/AN/A
#6
$15.4M9614%N/AN/A
#7
$2.5M26-19%N/AN/A
#8
$1190M6117-7%$31MN/A
#9
$8.9M64-41%N/AN/A
#10
$8.5M5926%N/AN/A
Add Company

What Is Ketryx?

Ketryx is the first and only connected application lifecycle management software for the life sciences industry. Our automation-based software enables companies building FDA-regulated software and AI-based applications to accelerate development through modern cloud-based tools while improving quality and compliance. Ketryx creates a real-time, and traceable, single source of truth by overlaying product development tools and connecting all items, risks, code, and tests. Teams reduce their time to market with automated documentation and improve their quality and compliance through the enforcement of SOPs across connected systems.

keywords:N/A

$18M

Total Funding

71

Number of Employees

$10.2M

Revenue (est)

109%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9M7145%$67.4M
#2
$7.9M71N/AN/A
#3
$20.6M718%N/A
#4
$11M71-1%N/A
#5
$22M7122%N/A